Palisade Bio Provides Update on Advancement of its Strategic Collaboration with Strand Life Sciences
PremiumPress ReleasesPalisade Bio Provides Update on Advancement of its Strategic Collaboration with Strand Life Sciences
1M ago
Palisade Bio provides update on collaboration with Strand Life Sciences
PremiumThe Fly
Palisade Bio provides update on collaboration with Strand Life Sciences
1M ago
Palisade Bio Announces Notice of Allowance for Canadian Patent Covering Lead Product Candidate, PALI-2108
PremiumPress Releases
Palisade Bio Announces Notice of Allowance for Canadian Patent Covering Lead Product Candidate, PALI-2108
1M ago
Palisade Bio reports Q1 EPS ($4.59) vs ($8.13) last year
PremiumThe FlyPalisade Bio reports Q1 EPS ($4.59) vs ($8.13) last year
2M ago
Palisade Bio Reports First Quarter 2024 Financial Results and Provides Business Update
PremiumPress Releases
Palisade Bio Reports First Quarter 2024 Financial Results and Provides Business Update
2M ago
Palisade Bio Welcomes New Board Member, Eyes Strategic Growth
PremiumCompany Announcements
Palisade Bio Welcomes New Board Member, Eyes Strategic Growth
3M ago
Palisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules
PremiumPress ReleasesPalisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules
3M ago
Palisade Bio ulcerative colitis data promising, says Maxim
PremiumThe Fly
Palisade Bio ulcerative colitis data promising, says Maxim
3M ago
Palisade Bio Inc trading resumes
PremiumThe Fly
Palisade Bio Inc trading resumes
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100